The increase in the prevalence of chronic diseases, growing demand for minimally invasive therapeutics, a surge in awareness regarding cancer and acceptance of interventional oncology procedures for detecting and treating cancer and rise in investments in research and development by biopharmaceutical industry players drive the growth of the global interventional oncology market. Based on product, …